ArticleBlood advances2022

Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.

Sebastian Stasik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.